ZNF419 and cancer: Transcription factor activity analysis revealed a significant upregulation of ZNF419 in CAFs (Figure 4C), a marker previously identified in studies as indicative of immune microenvironment alterations and an adverse prognosis in cancer (Song et al., 2021).